Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

2013551 citationsJournal Articlebronze Open Access

Authors

Jin Li · XinHua Hospital

Shukui Qin · XinHua Hospital

Jianming Xu · XinHua Hospital

Weijian Guo · XinHua Hospital

Jianping Xiong · XinHua Hospital

Yuxian Bai · XinHua Hospital

Guoping Sun · XinHua Hospital

Abstract

Apatinib showed improved PFS and OS in heavily pretreated patients with mGC who had experienced treatment failure with two or more chemotherapy regimens.

Topics & Keywords

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 31, Issue 26, pp. 3219-3225

DOI: 10.1200/jco.2013.48.8585

Field-Weighted Citation Impact: 24.17